Which of our Product Lines aligns with Your Mission?

Learn about our latest advancements, how each of them is a unique opportunity for your involvement in getting them out to market...

IoPlex's PVA sponge can be cut to shape

About IoPlex:

  • Control-release iodine 
  • No known microbial resistance to this dressing
  • Actively manages exudate
  • Color fades from black to white when it’s time to change.
  • Successful and Growing Sales in US

IoPlex Opportunities for you:

  • Patented granted 2019
  • FDA approved
  • Needs EU, Asia, S America approvals and market development
  • Ideal product for 3rd World and Developing Countries.

IoWipe used as a Hand and Face Sanitizer or Surface Wipe

About IoWipes:

  • Built on IoPlex technology
  • Sanitizing AND reusable
  • Skin AND surface applications
  • Reusable - lasts weeks and signals replacement
  • Changes color when it's time to replace

 

IoWipe Opportunities for you:

  • Market testing during COVID showed great acceptance and excitement
  • In Cosmetics:
    • No approval needed in most cosmetic or personal care applications
    • For treatment of Acne and other bacterial eruptions
    • Multi-million world-wide skin care market
  • As a Surface Wipe:
    • EPA approval required
    • Unlimited medical or commercial sanitizing applications
    • Portable personal sanitizing
  • As a Hand Sanitizer:
    • Less expensive and more effective than alcohol-based gels
    • Predicate for IoWipe is the IoPlex 510-k 

Comparison of I-Sorbe when dry, and when fully hydrated into a particulated gel.

About I-Sorbe:

  • Advancements on IoPlex: 
    • I-Sorbe's versatility produces Gels (ointment), powders, poultices or sheets
    • I-Sorbe powder absorbs more and 80 times its weight (vs 6x)
    • Can be combined to existing bandages: e.g. collagen and alginates
    • Changes color when its time to replace

I-Sorbe Opportunities for you:

  • Possible FDA 510-k, iodophor release rate and animal testing predicate
  • Easily and inexpensively manufactured
  • Provisional Patent (filed 2023) and Non-Provisional (filed 2024)
  • Active interest from wound care and medical companies
  • Military have been actively seeking Advanced Wound Care Dressings and have actively shown interest in funding grants specifically for I-Sorbe testing and production

For More About Our UpComing Products...

While IoPlex is taking the US Wound care market by storm, we've been developing more products and improving on the technology...

©Copyright. All rights reserved.

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.